Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Firefly Neuroscience (AIFF) Shares Issued (2020 - 2025)

Historic Shares Issued for Firefly Neuroscience (AIFF) over the last 6 years, with Q3 2025 value amounting to $10000.0.

  • Firefly Neuroscience's Shares Issued fell 6875.0% to $10000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $8.8 million, marking a year-over-year increase of 2753125.0%. This contributed to the annual value of $36000.0 for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Firefly Neuroscience's Shares Issued is $10000.0, which was down 6875.0% from $8.8 million recorded in Q1 2025.
  • Over the past 5 years, Firefly Neuroscience's Shares Issued peaked at $10.0 million during Q4 2021, and registered a low of -$56266.0 during Q3 2023.
  • Its 5-year average for Shares Issued is $1.7 million, with a median of $26799.0 in 2022.
  • Its Shares Issued has fluctuated over the past 5 years, first skyrocketed by 9990000.0% in 2021, then crashed by 9459.7% in 2022.
  • Quarter analysis of 5 years shows Firefly Neuroscience's Shares Issued stood at $10.0 million in 2021, then crashed by 99.92% to $8392.0 in 2022, then tumbled by 770.47% to -$56266.0 in 2023, then skyrocketed by 107.11% to $4000.0 in 2024, then soared by 150.0% to $10000.0 in 2025.
  • Its Shares Issued was $10000.0 in Q3 2025, compared to $8.8 million in Q1 2025 and $4000.0 in Q4 2024.